Groundbreaking Treatment for HIV/AIDS Developed by Israeli Research Team
People with AIDS might soon have the option to be treated with just a single vaccine dose, according to a new study from Tel Aviv University that shows the potential impact of a new and unique AIDS/HIV treatment.
The peer-reviewed study was led by Dr. Adi Barzel and Ph.D. student Alessio Nehmad, both from the TAU School of Neurobiology, Biochemistry and Biophysics, in collaboration with additional researchers from Israel and the United States.
More than 36 million deaths have been attributed worldwide to AIDS since it was first identified. As of 2020, about 37 million people were living with the disease, primarily in eastern and southern Africa.
While the disease is no longer always fatal, and while many HIV-positive people live full and long lives, currently available treatments do not provide a permanent cure. The research team led by Dr. Barzel aims to change that.
The goal of the research team was to genetically engineer type B white blood cells inside the body of a person with AIDS. Once modified, the blood cells would be able to secrete neutralizing antibodies against the HIV virus responsible for AIDS, eradicating it from the patient’s body.
Barzel said, “We are utilizing the very cause of the disease to combat it. Based on this study we can expect that over the coming years we will be able to produce in this way a medication for AIDS, for additional infectious diseases, and for certain types of cancer caused by a virus, such as cervical cancer, head and neck cancer, and more.” (JPost / VFI News)
Heal me, O Lord, and I shall be healed; save me, and I shall be saved, for you are my praise. - Jeremiah 17:14